Latest News

Roche Holding (SWX:ROP) has received CE marking for its cobas MPX-E assay, enabling simultaneous screening for HIV, hepatitis C, B, and E in blood donations. The company has also launched the cobas eplex RP3 respiratory panel, designed to test for up to 25 respiratory pathogens in a single rapid assay. These diagnostics products target blood safety, laboratory efficiency, and faster respiratory infection diagnosis across clinical settings. Roche Holding, trading at around CHF318.0,...

What the latest earnings and guidance tell you Beyond Meat (BYND) is back in focus after its delayed fourth quarter and full year 2025 results, alongside fresh first quarter 2026 revenue guidance and an after hours share price reaction that caught many investors' attention. For the fourth quarter of 2025, Beyond Meat reported sales of US$61.59 million, compared with US$76.66 million a year earlier, and a net income of US$409.85 million versus a net loss of US$44.86 million in the prior year...

Stock split and upcoming sector event draw attention Piper Sandler Companies (PIPR) has just implemented a four-for-one forward stock split, with trading beginning on a split-adjusted basis, a move that can influence liquidity and investor interest. See our latest analysis for Piper Sandler Companies. The stock split arrives as Piper Sandler’s share price sits at $77.83, with recent momentum reflected in a 1.6% 1 day share price return and a 3.7% 7 day share price return. The 1 year total...

Wondering whether RTX at around US$196 per share still offers value, or if most of the opportunity is already priced in? This article walks through that question in plain terms. The stock has delivered a 53.2% return over the last year and 113.3% over three years, with a 4.8% year to date move, a 1.7% gain over the last week and a 5.0% decline over the last month that may have changed how some investors view its risk and reward trade off. Recent headlines around RTX have focused on long term...

WellCell Holdings (SEHK:2477) is in focus after calling an extraordinary general meeting to seek approval for a four-for-one share subdivision, shortly after releasing full year 2025 results showing lower sales and net income. See our latest analysis for WellCell Holdings. At a latest share price of HK$19.46, WellCell Holdings has seen a 78.86% 1 month share price return and 57.83% year to date share price return, while the 1 year total shareholder return of 113.14% points to strong momentum...

Carolina Complete Health and WellCare of North Carolina have received regulatory approval to merge, consolidating Centene's Medicaid, Medicare, and Marketplace operations in the state. The combined organization will serve close to 1 million members in North Carolina. Separately, Centene subsidiaries are funding community health efforts, including support for the new St. Vincent Behavioral Health Campus in Los Angeles. Sunshine Health in Florida and Magnolia Health in Mississippi are...

AAR (NYSE:AIR) has secured a new long-term logistics support contract for the U.S. Navy and Marine Corps C-40A aircraft. The agreement expands AAR's government services backlog and adds to previously announced Air Force pallet work. The contract covers multi-year maintenance and support services, increasing AAR's exposure to recurring defense-related revenue. AAR focuses on aviation services, including maintenance, repair, and logistics support for both commercial and government customers...

Goldman Sachs Group (GS) is back in focus after regulators revised the Basel III framework, easing capital requirements for major banks, while commentary points to a projected pickup in mergers and acquisitions activity in 2026. See our latest analysis for Goldman Sachs Group. Goldman Sachs shares recently caught a bid on the Basel III revision and expectations for heavier M&A pipelines. While the 90 day share price return of 5.61% is weak, the 1 year total shareholder return of 72.31% and 5...

In March 2026, Intapp announced that Am Law 200 firm Buchanan Ingersoll & Rooney migrated Intapp Time to the cloud and adopted Intapp Terms to modernize timekeeping and strengthen compliance with client guidelines across matters. This win underscores growing demand among large professional services firms for AI-enabled, compliance-focused billing tools that streamline workflows and reduce manual data entry. We’ll now examine how Buchanan’s adoption of Intapp’s AI-powered cloud timekeeping...

In the recent past, Capital Southwest reported a very strong quarter, beating analysts’ revenue and EPS estimates and originating about US$244 million of new and follow-on investments across eight new and 16 existing portfolio companies. This performance placed Capital Southwest among the better-performing specialty finance names for the quarter, underlining healthy deal flow and active portfolio deployment. Now we’ll explore how this stronger-than-expected quarter, particularly the US$244...

Event context and recent share performance Kinsale Capital Group (KNSL) has recently drawn investor attention after a period of weaker share performance, with the stock showing a 12% decline over the past month and a similar move over the past 3 months. See our latest analysis for Kinsale Capital Group. Against this recent pullback, Kinsale Capital Group’s 1 year total shareholder return of a 30.7% decline contrasts with a 3 year total shareholder return of 13.26% and a 5 year total...

Lanxess (XTRA:LXS) has announced price increases for its sulfur based products in response to ongoing market and cost pressures. Bank of America has disclosed that it now holds over 5% of voting rights in Lanxess AG, crossing a key ownership threshold. Lanxess, a specialty chemicals producer, is active across sectors such as industrial manufacturing, agriculture, and consumer goods, where sulfur based products play an important role in multiple value chains. Price adjustments in this...

In late March 2026, reports suggested the FDA may delay authorization of certain oral nicotine products, including those Turning Point Brands has pending, as agency scientists weigh risks to new users and children. This hesitancy introduces fresh regulatory uncertainty around modern oral pouches, a category that has become central to Turning Point Brands’ growth plans. Next, we’ll examine how the potential for longer FDA approval timelines could reshape Turning Point Brands’ previously...

Multiple securities fraud lawsuits have been filed against Corcept Therapeutics (NasdaqCM:CORT), alleging the company misled investors about FDA concerns and trial efficacy for relacorilant. Plaintiffs claim Corcept did not fully disclose FDA reservations about the adequacy of clinical data before a Complete Response Letter declined approval for a specific indication. The FDA decision was followed by a sharp share price drop and a wave of class action filings from several law firms. The...

If you are wondering whether Unum Group's current share price reflects its underlying value, this breakdown aims to put the recent numbers and valuation signals into clear context. The stock last closed at US$74.17, with returns of 5.0% over 30 days, a 4.0% decline year to date, and a 4.2% decline over the past year. The 3 year and 5 year returns sit at 107.2% and 219.5% respectively. Recent coverage of Unum Group has focused on its position within the US insurance sector and how investors...

What is driving MasTec’s latest surge in attention? Recent analyst upgrades, heavier institutional buying, and a run of positive brokerage ratings have pushed MasTec (MTZ) into the spotlight. Many investors are reassessing the contractor’s infrastructure focused business model and recent share performance. See our latest analysis for MasTec. Their recent 0.7% 1 day share price return, 9.6% 7 day share price return, and 47.7% year to date share price return, alongside a 200.2% 1 year total...

Wondering if Integer Holdings at around US$86.85 is offering value or just price? This article walks through what the current share price might be implying about the business. The stock is flat over the past week and month and up 13.1% year to date, yet it has delivered a 25.2% decline over the past year and a 6.5% decline over five years, which can leave investors unsure how to read the story. Recent coverage has focused on putting these mixed returns into context for a medical equipment...

KKR (NYSE:KKR) is leading a $90 million Series C funding round in Coder, a provider of secure AI software development infrastructure. The firm has also closed a record $23 billion North America private equity fund in a challenging fundraising climate. KKR, trading at $91.23, sits at the center of two important themes for investors: large scale private equity capital and AI focused infrastructure. The stock shows mixed return patterns, with a 3 year gain of 89.2% and a 5 year gain of 84.5%,...

Recognition as a Top Community Bank Puts German American Bancorp in Focus German American Bancorp (GABC) has drawn fresh attention after ranking #29 among 223 community banks in S&P Global Market Intelligence’s 2025 performance review for institutions with $3b to $10b in assets. The recognition highlights how the Jasper, Indiana based bank’s operations and financial profile compare with peers. It also provides investors with another reference point as they consider the stock’s recent returns...

On March 30, 2026, Fortune Brands Innovations, Inc. filed a definitive proxy statement urging shareholders to vote against a proposal from investor John Chevedden that would reorganize the Board so every director stands for election at each annual meeting, ahead of the May 5, 2026 shareholder meeting. This board-structure debate highlights growing shareholder focus on Fortune Brands’ corporate governance and director accountability, adding a new dimension to how investors may assess the...

If you are wondering whether EastGroup Properties at around US$188 per share is offering good value today, it helps to first separate price action from underlying worth. Over the last week the stock returned 2.4%, while the 30 day return was a 3.6% decline, and over 1 year it recorded a 17.6% return, which can change how you think about both upside potential and risk. Recent coverage of EastGroup Properties has focused on its position as an industrial REIT and how investors are weighing that...

For investors asking whether Sherwin-Williams at around US$318 a share represents fair value, a bargain, or a premium price, this article looks directly at what the numbers indicate about the stock. The share price closed at US$318.00, with a 0.5% decline over 7 days, an 8.8% decline over 30 days, a 3.0% decline year to date, and a 5.8% decline over 1 year. The 3 year and 5 year returns stand at 45.8% and 31.1% respectively. These mixed returns put valuation in the spotlight as investors...

If you are wondering whether Enterprise Products Partners at around US$37.57 still offers value, the key question is how its current price compares with what investors are actually getting. The unit price has seen mixed short term moves, with a 3.9% decline over the last 7 days, a 0.5% return over the past month, and stronger returns of 16.8% year to date and 20.2% over the last year. Recent coverage has focused on Enterprise Products Partners as a large midstream energy name that some...

The United States market has experienced a positive trend, with a 1.9% increase over the last week and a substantial 24% rise over the past year, while earnings are projected to grow by 15% annually in the coming years. In such an environment, identifying stocks that are potentially undervalued can be appealing to investors seeking opportunities for growth, especially when there is notable insider activity suggesting confidence in these companies' prospects.